MEMPHASYS LIMITED. - Announcements

11.1%

0.4¢

Market Cap $7.934M

Technology Scientific & Technical Instruments

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive... Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.More

Corporate Spotlight

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.
View the full Corporate Spotlight

LATEST INTERVIEW

Announcements

Filter Results

All Price Sensitive Only

MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	11:02	310.37KB	Share
MEM	Final Director's Interest Notice MA		25/07/25	168.52KB	Share
MEM	Director Resignation		25/07/25	180.58KB	Share
MEM	Shareholder Meeting 8 August 2025 - Change of meeting venue		25/07/25	246.59KB	Share
MEM	Notice of General Meeting/Proxy Form		08/07/25	519.11KB	Share
MEM	CE Mark Lodged for Felix to Expand Global Access	PRICE SENSITIVE	30/06/25	311.05KB	Share
MEM	Director Appointment - Marjan Mikel		19/06/25	315.6KB	Share
MEM	Details of Auditor Appointment/Resignation		26/05/25	188.97KB	Share
MEM	MEM Successfully trials RoXsta Mega Cell High-Throughput	PRICE SENSITIVE	08/05/25	273.42KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	1.61MB	Share
MEM	s708A Cleansing Statement		17/04/25	169.88KB	Share
MEM	Application for quotation of securities - MEM		17/04/25	15.78KB	Share
MEM	Notification regarding unquoted securities - MEM		17/04/25	16.97KB	Share
MEM	Update - Proposed issue of securities - MEM		14/04/25	18.32KB	Share
MEM	$1.275M Placement to Accelerate Commercial Rollout	PRICE SENSITIVE	14/04/25	266.46KB	Share
MEM	Trading Halt	PRICE SENSITIVE	10/04/25	196.44KB	Share
MEM	Pause in Trading	PRICE SENSITIVE	10/04/25	115.36KB	Share
MEM	Proposed issue of securities - MEM		10/04/25	18.21KB	Share
MEM	RoXsta offers Effective Oxidative Stress Measurem't 4 Cattle	PRICE SENSITIVE	03/04/25	330.92KB	Share
MEM	Felix Trial Confirms Best-in-Class Performance	PRICE SENSITIVE	24/03/25	245.58KB	Share
MEM	Trading Halt	PRICE SENSITIVE	20/03/25	266.8KB	Share
MEM	MEM secures R&D Tax Rebate loan		13/03/25	223.01KB	Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/25	1.77MB	Share
MEM	Extension of Convertible Notes	PRICE SENSITIVE	28/02/25	173.72KB	Share
MEM	Investor Presentation Feb 25		25/02/25	4.33MB	Share
MEM	Felix Data lock complete and regulatory submission commenced	PRICE SENSITIVE	24/02/25	235.7KB	Share
MEM	Leading Brazilian Andrology Clinic to test Felix System	PRICE SENSITIVE	17/02/25	225.1KB	Share
MEM	Felix Clinical Trial complete, Data Lock expected in 2 weeks	PRICE SENSITIVE	11/02/25	215.48KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/01/25	510.97KB	Share
MEM	Publication Highlights Diagnostic Potential of RoXsta TM	PRICE SENSITIVE	16/01/25	232.43KB	Share
MEM	Heranova Felix System Utilisation Testing commences in China	PRICE SENSITIVE	06/01/25	229.72KB	Share
MEM	Top Up Offer Completion		23/12/24	203.51KB	Share
MEM	Notification regarding unquoted securities - MEM		20/12/24	18.13KB	Share
MEM	Application for quotation of securities - MEM		20/12/24	16.03KB	Share
MEM	Bovine Study commences to assess RoXsta antioxidant system	PRICE SENSITIVE	20/12/24	243.13KB	Share
MEM	Felix Clinical Registration Study completed, expanding mkt	PRICE SENSITIVE	18/12/24	217.16KB	Share
MEM	Letter of Intent with Heranova for Felix System Distribution	PRICE SENSITIVE	12/12/24	253.74KB	Share
MEM	Notification of cessation of securities - MEM		05/12/24	12.86KB	Share
MEM	Order for Felix System to Evaluate Suitability in UAE	PRICE SENSITIVE	05/12/24	228.33KB	Share
MEM	RoXsta System's Potential in Cattle Breeding being Explored	PRICE SENSITIVE	05/12/24	227.51KB	Share
MEM	Second Supplementary Prospectus		29/11/24	118.95KB	Share
MEM	Extension of convertible note		28/11/24	170.45KB	Share
MEM	Final Director's Interest Notice - RC		27/11/24	149.83KB	Share
MEM	Initial Director's Interest Notice - LE		27/11/24	168KB	Share
MEM	Results of Meeting		22/11/24	307.01KB	Share
MEM	Address to Shareholders		22/11/24	235.61KB	Share
MEM	Chair Appointment/Resignation		21/11/24	176.16KB	Share
MEM	Felix Clinical Trial Reaches 95% Completion	PRICE SENSITIVE	18/11/24	185.14KB	Share
MEM	RoXsta System Secures Provisional Patent Approval	PRICE SENSITIVE	15/11/24	206.85KB	Share
MEM	Notification regarding unquoted securities - MEM		08/11/24	17.02KB	Share
MEM	Application for quotation of securities - MEM		08/11/24	15.88KB	Share
MEM	Notification regarding unquoted securities - MEM		05/11/24	17.58KB	Share
MEM	Application for quotation of securities - MEM		05/11/24	15.8KB	Share
MEM	Completion of Placement and SPP offer	PRICE SENSITIVE	05/11/24	189.56KB	Share
MEM	Alteration to Notice of Meeting (AGM venue)		31/10/24	535.04KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/24	327.92KB	Share
MEM	Results of Meeting		25/10/24	61.8KB	Share
MEM	MEM Investor Presentation	PRICE SENSITIVE	25/10/24	4.57MB	Share
MEM	Investor Webinar Invitation		24/10/24	131.42KB	Share
MEM	Felix Trial registration update	PRICE SENSITIVE	24/10/24	168.27KB	Share
MEM	Update - Proposed issue of securities - MEM		22/10/24	33KB	Share
MEM	Extension of SPP offer		22/10/24	205.54KB	Share
MEM	Supplementary Prospectus disclosure update		18/10/24	150.83KB	Share
MEM	Equine study commences with 12mth commercialisation expected	PRICE SENSITIVE	18/10/24	179.14KB	Share
MEM	Notice of Annual General Meeting/Proxy Form		11/10/24	456.78KB	Share
MEM	Supplementary Prospectus		08/10/24	159.33KB	Share
MEM	Target Market Determination (SPP Offer)		25/09/24	249.2KB	Share
MEM	Notice of General Meeting/Proxy Form		25/09/24	425.58KB	Share
MEM	Update - Proposed issue of securities - MEM		23/09/24	33KB	Share
MEM	Patent filed for novel antioxidant assay system, RoXsta		23/09/24	188.17KB	Share
MEM	Prospectus	PRICE SENSITIVE	20/09/24	380.04KB	Share
MEM	Annual Financial Report for the year ended 30 June 2024		18/09/24	1.31MB	Share
MEM	Proposed issue of securities - MEM		17/09/24	18.91KB	Share
MEM	Short term loan facility	PRICE SENSITIVE	17/09/24	195.35KB	Share
MEM	Positive initial study results - Felix equine application	PRICE SENSITIVE	16/09/24	184.21KB	Share
MEM	Reinstatement to Official Quotation	PRICE SENSITIVE	12/09/24	406.86KB	Share
MEM	Proposed issue of securities - MEM		12/09/24	32.54KB	Share
MEM	A$2 million capital raising	PRICE SENSITIVE	12/09/24	285.01KB	Share
MEM	Voluntary Suspension	PRICE SENSITIVE	11/09/24	229.26KB	Share
MEM	Trading Halt	PRICE SENSITIVE	09/09/24	231.97KB	Share
MEM	Retraction of Cleansing Notice dated 29 August 2024		06/09/24	164.69KB	Share
MEM	Response to ASX Query	PRICE SENSITIVE	06/09/24	776.38KB	Share
MEM	Equine fertility study positions Felix as leading technology	PRICE SENSITIVE	04/09/24	238.42KB	Share
MEM	Notification of cessation of securities - MEM		02/09/24	12.89KB	Share
MEM	2024 Corporate Governance Statement and App4G		30/08/24	535.75KB	Share
MEM	Securities Trading Policy		30/08/24	237.91KB	Share
MEM	Preliminary Final Report	PRICE SENSITIVE	30/08/24	1.11MB	Share
MEM	Cleansing Statement		29/08/24	166.97KB	Share
MEM	Notification regarding unquoted securities - MEM		29/08/24	16.94KB	Share
MEM	Application for quotation of securities - MEM		29/08/24	15.72KB	Share
MEM	Proposed issue of securities - MEM		27/08/24	17.54KB	Share
MEM	Notification of cessation of securities - MEM		01/08/24	12.88KB	Share
MEM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	495.49KB	Share
MEM	$1M secured from major shareholder and R&D Tax Rebate loan		29/07/24	236.79KB	Share
MEM	Felix sales clinical trial and Oxidative Stress devel update	PRICE SENSITIVE	24/07/24	338.25KB	Share
MEM	Animal activity update - oxidative stress measurement system	PRICE SENSITIVE	19/07/24	227.87KB	Share
MEM	Details of Company Address		06/06/24	147.36KB	Share
MEM	Dr David Ali appointed full-time Chief Executive Officer	PRICE SENSITIVE	06/06/24	177.33KB	Share
MEM	s708 cleansing statement		03/06/24	165.02KB	Share
MEM	Notification regarding unquoted securities - MEM		03/06/24	14.46KB	Share

MEM Quarterly Activities/Appendix 4C Cash Flow Report
11:02	PRICE SENSITIVE	310.37KB	Share
MEM Final Director's Interest Notice MA
25/07/25		168.52KB	Share
MEM Director Resignation
25/07/25		180.58KB	Share
MEM Shareholder Meeting 8 August 2025 - Change of meeting venue
25/07/25		246.59KB	Share
MEM Notice of General Meeting/Proxy Form
08/07/25		519.11KB	Share
MEM CE Mark Lodged for Felix to Expand Global Access
30/06/25	PRICE SENSITIVE	311.05KB	Share
MEM Director Appointment - Marjan Mikel
19/06/25		315.6KB	Share
MEM Details of Auditor Appointment/Resignation
26/05/25		188.97KB	Share
MEM MEM Successfully trials RoXsta Mega Cell High-Throughput
08/05/25	PRICE SENSITIVE	273.42KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	1.61MB	Share
MEM s708A Cleansing Statement
17/04/25		169.88KB	Share
MEM Application for quotation of securities - MEM
17/04/25		15.78KB	Share
MEM Notification regarding unquoted securities - MEM
17/04/25		16.97KB	Share
MEM Update - Proposed issue of securities - MEM
14/04/25		18.32KB	Share
MEM $1.275M Placement to Accelerate Commercial Rollout
14/04/25	PRICE SENSITIVE	266.46KB	Share
MEM Trading Halt
10/04/25	PRICE SENSITIVE	196.44KB	Share
MEM Pause in Trading
10/04/25	PRICE SENSITIVE	115.36KB	Share
MEM Proposed issue of securities - MEM
10/04/25		18.21KB	Share
MEM RoXsta offers Effective Oxidative Stress Measurem't 4 Cattle
03/04/25	PRICE SENSITIVE	330.92KB	Share
MEM Felix Trial Confirms Best-in-Class Performance
24/03/25	PRICE SENSITIVE	245.58KB	Share
MEM Trading Halt
20/03/25	PRICE SENSITIVE	266.8KB	Share
MEM MEM secures R&D Tax Rebate loan
13/03/25		223.01KB	Share
MEM Half Yearly Report and Accounts
28/02/25	PRICE SENSITIVE	1.77MB	Share
MEM Extension of Convertible Notes
28/02/25	PRICE SENSITIVE	173.72KB	Share
MEM Investor Presentation Feb 25
25/02/25		4.33MB	Share
MEM Felix Data lock complete and regulatory submission commenced
24/02/25	PRICE SENSITIVE	235.7KB	Share
MEM Leading Brazilian Andrology Clinic to test Felix System
17/02/25	PRICE SENSITIVE	225.1KB	Share
MEM Felix Clinical Trial complete, Data Lock expected in 2 weeks
11/02/25	PRICE SENSITIVE	215.48KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
23/01/25	PRICE SENSITIVE	510.97KB	Share
MEM Publication Highlights Diagnostic Potential of RoXsta TM
16/01/25	PRICE SENSITIVE	232.43KB	Share
MEM Heranova Felix System Utilisation Testing commences in China
06/01/25	PRICE SENSITIVE	229.72KB	Share
MEM Top Up Offer Completion
23/12/24		203.51KB	Share
MEM Notification regarding unquoted securities - MEM
20/12/24		18.13KB	Share
MEM Application for quotation of securities - MEM
20/12/24		16.03KB	Share
MEM Bovine Study commences to assess RoXsta antioxidant system
20/12/24	PRICE SENSITIVE	243.13KB	Share
MEM Felix Clinical Registration Study completed, expanding mkt
18/12/24	PRICE SENSITIVE	217.16KB	Share
MEM Letter of Intent with Heranova for Felix System Distribution
12/12/24	PRICE SENSITIVE	253.74KB	Share
MEM Notification of cessation of securities - MEM
05/12/24		12.86KB	Share
MEM Order for Felix System to Evaluate Suitability in UAE
05/12/24	PRICE SENSITIVE	228.33KB	Share
MEM RoXsta System's Potential in Cattle Breeding being Explored
05/12/24	PRICE SENSITIVE	227.51KB	Share
MEM Second Supplementary Prospectus
29/11/24		118.95KB	Share
MEM Extension of convertible note
28/11/24		170.45KB	Share
MEM Final Director's Interest Notice - RC
27/11/24		149.83KB	Share
MEM Initial Director's Interest Notice - LE
27/11/24		168KB	Share
MEM Results of Meeting
22/11/24		307.01KB	Share
MEM Address to Shareholders
22/11/24		235.61KB	Share
MEM Chair Appointment/Resignation
21/11/24		176.16KB	Share
MEM Felix Clinical Trial Reaches 95% Completion
18/11/24	PRICE SENSITIVE	185.14KB	Share
MEM RoXsta System Secures Provisional Patent Approval
15/11/24	PRICE SENSITIVE	206.85KB	Share
MEM Notification regarding unquoted securities - MEM
08/11/24		17.02KB	Share
MEM Application for quotation of securities - MEM
08/11/24		15.88KB	Share
MEM Notification regarding unquoted securities - MEM
05/11/24		17.58KB	Share
MEM Application for quotation of securities - MEM
05/11/24		15.8KB	Share
MEM Completion of Placement and SPP offer
05/11/24	PRICE SENSITIVE	189.56KB	Share
MEM Alteration to Notice of Meeting (AGM venue)
31/10/24		535.04KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
30/10/24	PRICE SENSITIVE	327.92KB	Share
MEM Results of Meeting
25/10/24		61.8KB	Share
MEM MEM Investor Presentation
25/10/24	PRICE SENSITIVE	4.57MB	Share
MEM Investor Webinar Invitation
24/10/24		131.42KB	Share
MEM Felix Trial registration update
24/10/24	PRICE SENSITIVE	168.27KB	Share
MEM Update - Proposed issue of securities - MEM
22/10/24		33KB	Share
MEM Extension of SPP offer
22/10/24		205.54KB	Share
MEM Supplementary Prospectus disclosure update
18/10/24		150.83KB	Share
MEM Equine study commences with 12mth commercialisation expected
18/10/24	PRICE SENSITIVE	179.14KB	Share
MEM Notice of Annual General Meeting/Proxy Form
11/10/24		456.78KB	Share
MEM Supplementary Prospectus
08/10/24		159.33KB	Share
MEM Target Market Determination (SPP Offer)
25/09/24		249.2KB	Share
MEM Notice of General Meeting/Proxy Form
25/09/24		425.58KB	Share
MEM Update - Proposed issue of securities - MEM
23/09/24		33KB	Share
MEM Patent filed for novel antioxidant assay system, RoXsta
23/09/24		188.17KB	Share
MEM Prospectus
20/09/24	PRICE SENSITIVE	380.04KB	Share
MEM Annual Financial Report for the year ended 30 June 2024
18/09/24		1.31MB	Share
MEM Proposed issue of securities - MEM
17/09/24		18.91KB	Share
MEM Short term loan facility
17/09/24	PRICE SENSITIVE	195.35KB	Share
MEM Positive initial study results - Felix equine application
16/09/24	PRICE SENSITIVE	184.21KB	Share
MEM Reinstatement to Official Quotation
12/09/24	PRICE SENSITIVE	406.86KB	Share
MEM Proposed issue of securities - MEM
12/09/24		32.54KB	Share
MEM A$2 million capital raising
12/09/24	PRICE SENSITIVE	285.01KB	Share
MEM Voluntary Suspension
11/09/24	PRICE SENSITIVE	229.26KB	Share
MEM Trading Halt
09/09/24	PRICE SENSITIVE	231.97KB	Share
MEM Retraction of Cleansing Notice dated 29 August 2024
06/09/24		164.69KB	Share
MEM Response to ASX Query
06/09/24	PRICE SENSITIVE	776.38KB	Share
MEM Equine fertility study positions Felix as leading technology
04/09/24	PRICE SENSITIVE	238.42KB	Share
MEM Notification of cessation of securities - MEM
02/09/24		12.89KB	Share
MEM 2024 Corporate Governance Statement and App4G
30/08/24		535.75KB	Share
MEM Securities Trading Policy
30/08/24		237.91KB	Share
MEM Preliminary Final Report
30/08/24	PRICE SENSITIVE	1.11MB	Share
MEM Cleansing Statement
29/08/24		166.97KB	Share
MEM Notification regarding unquoted securities - MEM
29/08/24		16.94KB	Share
MEM Application for quotation of securities - MEM
29/08/24		15.72KB	Share
MEM Proposed issue of securities - MEM
27/08/24		17.54KB	Share
MEM Notification of cessation of securities - MEM
01/08/24		12.88KB	Share
MEM Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	495.49KB	Share
MEM $1M secured from major shareholder and R&D Tax Rebate loan
29/07/24		236.79KB	Share
MEM Felix sales clinical trial and Oxidative Stress devel update
24/07/24	PRICE SENSITIVE	338.25KB	Share
MEM Animal activity update - oxidative stress measurement system
19/07/24	PRICE SENSITIVE	227.87KB	Share
MEM Details of Company Address
06/06/24		147.36KB	Share
MEM Dr David Ali appointed full-time Chief Executive Officer
06/06/24	PRICE SENSITIVE	177.33KB	Share
MEM s708 cleansing statement
03/06/24		165.02KB	Share
MEM Notification regarding unquoted securities - MEM
03/06/24		14.46KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change -0.001(11.1%)		Mkt cap ! $7.934M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.4¢	$60.70K	15.16M

Buyers (Bids)

No.	Vol.	Price($)
9	4460257	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	1066202	2

View Market Depth

No.	Vol.	Price($)
9	4460257	0.003
8	5494011	0.002
6	9750024	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	1066202	2
0.005	5087626	10
0.006	5039975	12
0.007	8989817	6
0.008	1782500	5

Last trade - 15.12pm 30/07/2025 (20 minute delay)


Last 0.4¢		Change -0.001 ( 11.1 %)
Open	High	Low	Volume
0.5¢	0.5¢	0.4¢	4996013
Last updated 15.36pm 30/07/2025 ?

MEM (ASX) Chart

MEMPHASYS LIMITED. - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories